Target intelligence / Profile preview

Golgin A4 pseudogene 1 (null)

Target
null
Molecular classification
Other (Pseudogene)
01

Overview

This entity is a pseudogene named Golgin A4 pseudogene 1 (GOLGA4P1), associated with Ensembl ID ENSG00000227291. Pseudogenes are DNA sequences similar to known protein-coding genes but contain mutations or disruptions that preclude normal protein translation. While some pseudogenes may be transcribed and have functional RNA-based regulatory activity—such as acting as microRNA decoys or sources of small interfering RNAs—a majority, including GOLGA4P1, do not encode functional proteins[2][5]. There is no evidence that this pseudogene acts as a receptor, enzyme, transporter, or classical drug target. It also does not have established roles as a disease biomarker or therapeutic target. Key Points: - Golgin A4 pseudogene 1 is not a functional protein-coding gene[4][5]. - Pseudogenes are generally not considered drug targets or conventional biological targets[2][5]. - They may, in some cases, have regulatory or noncoding RNA functions, but most are functionally silent, and no disease or therapeutic relevance is published for GOLGA4P1[2][5]. - GOLGA4, the parent gene family, is involved in Golgi apparatus function and vesicular trafficking, but this does not extend therapeutically to the pseudogene itself[1]. This target is not an approved or recognized molecular target for therapy or drug development purposes.

Other names
GOLGA4P1Golgi autoantigen, golgin subfamily a, 4 pseudogene 1
02

Mechanism of action

null

03

Biological functions

Possible regulation of gene expression through noncoding RNA mechanisms such as miRNA decoy, RNA interference (if transcribed)[2][5]
04

Disease associations

Other (Some pseudogenes can play regulatory roles in cancer and other diseases, but there is no specific evidence for this one)[2]

Beyond the preview

Go deeper on Golgin A4 pseudogene 1 (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Golgin A4 pseudogene 1 (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call